Welcome to the Pharmacists COPD Website.

This site is brought to you by Pfizer Canada and Boehringer Ingelheim (Canada) Ltd. and contains a CCCEP Approved Chronic Obstructive Pulmonary Disease (COPD) continuing education (CE) program.

This education program is interactive and includes Practice Pearls, Counselling Briefs and Case Studies. The Practice Pearls contain clinical tips that can help you in your daily practice or useful background information on a topic. Counselling Briefs may assist you in patient counselling on COPD medication(s). The case studies allow you to check your knowledge as you read through the education program.*

You can earn continuing education credits by completing the CE Post Test. If you achieve a grade of 70% or higher, you will be able to print off a certificate of completion which you may forward to your preferred licensing province.



Written by:

Karen Agro, BScPhm, PharmD
Christine Folia, BScPhm, PharmD
Paul Agro, BScPhm
Dave Millar, BScPhm

Agro Health Associates Inc.
Flamborough, Ontario, Canada
www.agrohealth.com


Reviewed by:

Raymond Gottschalk, M.B, Ch.B., F.R.C.P.(C)
Respiratory Physician
The Asthma & Respiratory Health Centre
Hamilton, Ontario, Canada

Charles D. Bayliff, PharmD
Pharmaceutical Care Co-ordinator
London Health Sciences Centre
London, Ontario, Canada

Revised February 2003


This continuing education lesson is designed primarily for
community pharmacists and has been accredited by the
Canadian Council on Continuing Education in
Pharmacy (CCCEP) for 3 CEUs .

Accredited 2004, pending re-accreditation June 2005
CCCEP File #: 939-0203


Sponsored by an unrestricted educational grant from Pfizer Canada and Boehringer Ingelheim (Canada) Ltd.

* There are variety of spacer devices/holding chambers available. A review of the features/benefits and appropriate use is beyond the scope of this Continuing Education lesson. Pharmacists are encouraged to maintain their understanding of these devices, in order to provide optimal care to their patients with COPD and other breathing disorders.

© 2002  Pfizer Canada and Boehringer Ingelheim (Canada) Ltd./Ltée. All rights reserved. Terms of use